These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 862429

  • 1. Comparison of synemol cream and other topical corticosteroid creams using the vasoconstrictor bioassay.
    Strand LJ, Flatman CJ, Northway CS, Evans CD.
    Cutis; 1977 May; 19(5):689-91. PubMed ID: 862429
    [Abstract] [Full Text] [Related]

  • 2. Potency ranking of two new topical corticosteroid creams containing 0.1% desonide or 0.05% halometasone utilising the human skin blanching assay.
    Meyer E, Smith EW, Haigh JM, Kanfer I.
    Arzneimittelforschung; 1988 Dec; 38(12):1840-3. PubMed ID: 3245859
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The evaluation of a novel corticosteroid formulation, fluocinonide in "FAPG" base, in the blanching test.
    Coldman MF, Lockerbie L, Laws EA.
    Br J Dermatol; 1971 Dec; 85(6):573-6. PubMed ID: 4947552
    [No Abstract] [Full Text] [Related]

  • 5. Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
    Szadurski J, Renz F, Gasser D.
    Dermatologica; 1976 Dec; 153(4):236-42. PubMed ID: 1017533
    [Abstract] [Full Text] [Related]

  • 6. Diflorasone diacetate: vasoconstrictor activity and clinical efficacy of a new topical corticosteroid.
    Bluefarb SM, Howard FM, Leibsohn E, Schlagel CA, Wexler L.
    J Int Med Res; 1976 Dec; 4(6):454-61. PubMed ID: 800385
    [Abstract] [Full Text] [Related]

  • 7. Diprosone (betamethasone dipropionate) Creame 0-05%. Review and report of a multicentre study.
    Chambers WB, Cash WS, Marinaccio A.
    J Int Med Res; 1976 Dec; 4(3 Suppl):1-26. PubMed ID: 799993
    [No Abstract] [Full Text] [Related]

  • 8. Sicorten: a synthetic corticosteroid for topical treatment of common dermatoses.
    Majerus JP, Reiffers-Mettelock J.
    J Int Med Res; 1986 Dec; 14(1):46-9. PubMed ID: 2937673
    [Abstract] [Full Text] [Related]

  • 9. Corticosteroid-induced cutaneous atrophy and telangiectasia. Experimental production associated with weight loss in rats.
    Smith JG, Wehr RF, Chalker DK.
    Arch Dermatol; 1976 Aug; 112(8):1115-7. PubMed ID: 952530
    [Abstract] [Full Text] [Related]

  • 10. [Comparative studies on the vasoconstrictor effect of various corticosteroids].
    Bickhardt R.
    Hautarzt; 1972 Jul; 23(7):301-5. PubMed ID: 4655109
    [No Abstract] [Full Text] [Related]

  • 11. Antiinflammatory activity and thymolytic effect of a new corticosteroid ester (I.S.F. 2073) by topical application.
    Banfi S, Cornelli U, Carpi C.
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):126-32. PubMed ID: 812657
    [No Abstract] [Full Text] [Related]

  • 12. Topical halcinonide and betamethasone valerate effects on plasma cortisol: acute and subacute usage studies.
    Gomez EC, Kaminester L, Frost P.
    Arch Dermatol; 1977 Sep; 113(9):1196-202. PubMed ID: 332089
    [Abstract] [Full Text] [Related]

  • 13. Bioassay system for formulations of topically applied glucocorticosteroids.
    Stoughton RB.
    Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246
    [No Abstract] [Full Text] [Related]

  • 14. Precise evaluation of topically applied corticosteroid potency. Modification of the Stoughton-McKenzie assay.
    Place VA, Velazquez JG, Burdick KH.
    Arch Dermatol; 1970 May; 101(5):531-7. PubMed ID: 5444076
    [No Abstract] [Full Text] [Related]

  • 15. Topical corticosteroid allergy in an urban Australian centre.
    Keegel T, Saunders H, Milne R, Sajjachareonpong P, Fletcher A, Nixon R.
    Contact Dermatitis; 2004 Jan; 50(1):6-14. PubMed ID: 15059096
    [Abstract] [Full Text] [Related]

  • 16. Are generic formulations equivalent to trade name topical glucocorticoids?
    Stoughton RB.
    Arch Dermatol; 1987 Oct; 123(10):1312-4. PubMed ID: 3662563
    [Abstract] [Full Text] [Related]

  • 17. Mometasone furoate ointment and cream 0.1 percent in treatment of psoriasis: comparison with ointment and cream formulations of fluocinolone acetonide 0.025 percent and triamcinolone acetonide 0.1 percent.
    Medansky RS, Bressinck R, Cole GW, Deeken JH, Ellis CN, Guin JD, Herndon JH, Lasser AE, Leibsohn E, Menter MA.
    Cutis; 1988 Nov; 42(5):480-5. PubMed ID: 3058398
    [Abstract] [Full Text] [Related]

  • 18. [Diprosone cream: its value in daily dermatologic practice].
    Lille Med; 1975 Jan; 20(1):61-3. PubMed ID: 1134174
    [No Abstract] [Full Text] [Related]

  • 19. Comparative bio-availability of proprietary topical corticosteroid preparations; vasoconstrictor assays on thirty creams and gels.
    Barry BW, Woodford R.
    Br J Dermatol; 1974 Sep; 91(3):323-38. PubMed ID: 4611447
    [No Abstract] [Full Text] [Related]

  • 20. The evaluation of several topical corticosteroid preparations in the blanching test.
    Coldman MF, Lockerbie L, Laws EA.
    Br J Dermatol; 1971 Oct; 85(4):381-7. PubMed ID: 5125641
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.